Search - tctmd.com

Displaying 421 - 440 of 1142

Sort: Relevancy | Date

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Conference News VIVA 2019

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

L.A. McKeown

November 05, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Daily News

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

Todd Neale

October 29, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Daily News

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

L.A. McKeown

October 15, 2019

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Shelley Wood

October 14, 2019

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

News Conference News TCT 2019

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

Michael O'Riordan

September 30, 2019

News Conference News TCT 2019

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Yael L. Maxwell

September 29, 2019

Advertisement

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

IN.PACT Global Registry Shows Continued Safety, Efficacy at 4 Years for Paclitaxel DCB

TCTMD’s Top 10 Most Popular Stories for October 2019

Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Implantable Cardiac Monitor May Reduce Delays to Hospital in High-Risk ACS

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Recurrent Events Common Among Young Patients With CAD

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content